Corrigendum: Proteome Analysis of USP7 Substrates Revealed Its Role in Melanoma Through PI3K/Akt/FOXO and AMPK Pathways (Front. Oncol, (2021), 11, (650165), 10.3389/fonc.2021.650165)

3Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

In the original article, there was a mistake in Figure 2C as published. In fact, we initially left a gap between 116kD and 96kD WB bands in the manuscript (Figure 2C), which might not be clear enough, eventually leading to a misunderstanding of the bands. Actually, the PARP antibody (Abclonal, A19596) we used in this study could detect the full length PARP (116kDa), as well as the cleaved PARP (96 kDa). The short time exposure showed an increased but fuzzy band of the cleaved PARP. As the PARP cleavage serves as a better indicator of apoptosis triggering, that we examine the cleaved PARP (96 kDa) with a long time exposure. The corrected Figure 2C appears below.

Cite

CITATION STYLE

APA

Gao, L., Zhu, D., Wang, Q., Bao, Z., Yin, S., Qiang, H., … Jia, J. (2021, July 23). Corrigendum: Proteome Analysis of USP7 Substrates Revealed Its Role in Melanoma Through PI3K/Akt/FOXO and AMPK Pathways (Front. Oncol, (2021), 11, (650165), 10.3389/fonc.2021.650165). Frontiers in Oncology. Frontiers Media S.A. https://doi.org/10.3389/fonc.2021.736438

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free